New patent expiration for Allergan drug GELNIQUE 3%
Annual Drug Patent Expirations for GELNIQUE+3%25 Gelnique 3% is a drug marketed by Allergan and is included in one NDA. There is one patent protecting this drug. Drug patent litigation…
The post New patent expiration for Allergan drug GELNIQUE 3% appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.